Related Experiment Videos
FGFR1 signaling in rheumatoid arthritis: Mechanisms of bone destruction and therapeutic targeting (Review)
Changzhong Qian1, Zhenyu Zhang1, Xian Wu1
1Institute of Integrated Chinese and Western Medicine, Affiliated Hospital of Jiangnan University, Wuxi, Jiangsu 214131, P.R. China.
Abstract:
Rheumatoid arthritis (RA) is an inflammatory, systematic and articular autoimmune disease characterized by progressive cartilage degradation and bone erosion, leading to irreversible joint deformity. Fibroblast growth factor receptor 1 (FGFR1) is a key mediator of RA‑associated bone loss. Within inflamed joints, FGFR1 expression is markedly upregulated in synovial fibroblasts, osteoclasts and chondrocytes. Ligand engagement drives receptor dimerization and kinase activation, activating PI3K/Akt, MAPK and STAT signaling cascades that amplify cytokine release, matrix metalloproteinase expression and osteoclastogenesis. These converging signals promote cartilage degradation and cortical bone erosion, fueling progressive deformity. Targeting FGFR1 markedly attenuates bone loss and disease severity in both murine and humanized models. The present review aimed to summarize the potential of FGFR1 as a tractable therapeutic node for RA bone destruction.
Related Concept Videos
The JAK-STAT Signaling Pathway
Rheumatic Heart Disease I: Introduction
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
TGF - β Signaling Pathway
Osteoclasts in Bone Remodeling
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF